TUESDAY, March 22, 2022 (HealthDay News) The incidence rates of metastatic prostate cancer (mPCa) have increased significantly and coincide with the U.S. Preventive Services Task Force (USPSTF) recommendations against prostate cancer screening, according to a study published online March 14 in JAMA Network Open. Mihir M. Desai, M.D., from University of Southern California in […]
Keck Medicine of USC study shows that the incidence rate of metastatic prostate cancer rose as much as 43% in men 75 and older and 41% in men 45-74 after routine prostate cancer screenings were no longer recommended